Mygem 200mg

Brand: Mygem 200mg
Composition: Gemcitabine
Company: Mylan
Form : Injection
Packing:  1 vail  in 1 box
Share :

Related Products

Mygem is a generic version of Gemcitabine, a medication used to treat certain types of cancer, including:
  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)
Composition: Mygem is a single-ingredient product containing Gemcitabine, a nucleoside analog that works by inhibiting the action of DNA synthesis and repair enzymes in cancer cells. Mechanism of Action: Gemcitabine works by inhibiting the action of DNA synthesis and repair enzymes, leading to the death of cancer cells and the inhibition of their growth. Uses: Mygem is used to treat:
  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)
Dosage: The recommended dosage of Mygem is:
  • 200mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity
Side Effects: Common side effects of Mygem include:
  • Nausea and vomiting
  • Fatigue
  • Anemia
  • Low white blood cell count
  • Low platelet count
  • Increased risk of bleeding
  • Increased risk of infection
  • Hair loss
  • Skin rash
  • Diarrhea
Recommendation: Mygem is recommended for patients with breast cancer, lung cancer, ovarian cancer, pancreatic cancer, or bladder cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment. Important Note: Patients should not take Mygem if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Mygem. Please note that Mygem is a generic version of Gemcitabine and may be available in different countries under different brand names. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule. It’s worth noting that Mygem is a cytotoxic medication and should only be used under the supervision of a qualified healthcare professional.

Mygem is a generic version of Gemcitabine, a medication used to treat certain types of cancer, including:

  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)

Composition:

Mygem is a single-ingredient product containing Gemcitabine, a nucleoside analog that works by inhibiting the action of DNA synthesis and repair enzymes in cancer cells.

Mechanism of Action:

Gemcitabine works by inhibiting the action of DNA synthesis and repair enzymes, leading to the death of cancer cells and the inhibition of their growth.

Uses:

Mygem is used to treat:

  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)

Dosage:

The recommended dosage of Mygem is:

  • 200mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Mygem include:

  • Nausea and vomiting
  • Fatigue
  • Anemia
  • Low white blood cell count
  • Low platelet count
  • Increased risk of bleeding
  • Increased risk of infection
  • Hair loss
  • Skin rash
  • Diarrhea

Recommendation:

Mygem is recommended for patients with breast cancer, lung cancer, ovarian cancer, pancreatic cancer, or bladder cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Mygem if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Mygem.

Please note that Mygem is a generic version of Gemcitabine and may be available in different countries under different brand names. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

It’s worth noting that Mygem is a cytotoxic medication and should only be used under the supervision of a qualified healthcare professional.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Mygem is a generic version of Gemcitabine, a medication used to treat certain types of cancer, including:

  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)

Composition:

Mygem is a single-ingredient product containing Gemcitabine, a nucleoside analog that works by inhibiting the action of DNA synthesis and repair enzymes in cancer cells.

Mechanism of Action:

Gemcitabine works by inhibiting the action of DNA synthesis and repair enzymes, leading to the death of cancer cells and the inhibition of their growth.

Uses:

Mygem is used to treat:

  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)

Dosage:

The recommended dosage of Mygem is:

  • 200mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Mygem include:

  • Nausea and vomiting
  • Fatigue
  • Anemia
  • Low white blood cell count
  • Low platelet count
  • Increased risk of bleeding
  • Increased risk of infection
  • Hair loss
  • Skin rash
  • Diarrhea

Recommendation:

Mygem is recommended for patients with breast cancer, lung cancer, ovarian cancer, pancreatic cancer, or bladder cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Mygem if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Mygem.

Please note that Mygem is a generic version of Gemcitabine and may be available in different countries under different brand names. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

It’s worth noting that Mygem is a cytotoxic medication and should only be used under the supervision of a qualified healthcare professional.

Reviews

There are no reviews yet.

Be the first to review “Mygem 200mg”

Your email address will not be published. Required fields are marked *

Mygem is a generic version of Gemcitabine, a medication used to treat certain types of cancer, including:

  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)

Composition:

Mygem is a single-ingredient product containing Gemcitabine, a nucleoside analog that works by inhibiting the action of DNA synthesis and repair enzymes in cancer cells.

Mechanism of Action:

Gemcitabine works by inhibiting the action of DNA synthesis and repair enzymes, leading to the death of cancer cells and the inhibition of their growth.

Uses:

Mygem is used to treat:

  • Breast cancer (in combination with chemotherapy)
  • Lung cancer (non-small cell lung cancer, in combination with chemotherapy)
  • Ovarian cancer (in combination with chemotherapy)
  • Pancreatic cancer (in combination with chemotherapy)
  • Bladder cancer (in combination with chemotherapy)

Dosage:

The recommended dosage of Mygem is:

  • 200mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Mygem include:

  • Nausea and vomiting
  • Fatigue
  • Anemia
  • Low white blood cell count
  • Low platelet count
  • Increased risk of bleeding
  • Increased risk of infection
  • Hair loss
  • Skin rash
  • Diarrhea

Recommendation:

Mygem is recommended for patients with breast cancer, lung cancer, ovarian cancer, pancreatic cancer, or bladder cancer who have not responded to previous treatments. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Mygem if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Mygem.

Please note that Mygem is a generic version of Gemcitabine and may be available in different countries under different brand names. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

It’s worth noting that Mygem is a cytotoxic medication and should only be used under the supervision of a qualified healthcare professional.

Reviews

There are no reviews yet.

Be the first to review “Mygem 200mg”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For Mygem 200mg